St. Jude proceeds with first U.S. trial of hypertension device

06/7/2013 | MassDevice.com (Boston)

The FDA has granted St. Jude Medical an investigational device exemption to conduct the first U.S. clinical study of its EnligHTN multielectrode device, which uses radiofrequency energy to disrupt the renal nerves believed to control blood pressure. The trial will involve about 590 patients with drug-resistant hypertension.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN